Harold R Papiska

Title: Harold R. Papiska: Innovator in Antibiotic Development

Introduction

Harold R. Papiska is a notable inventor based in Indianapolis, IN (US), recognized for his contributions to the field of antibiotics. His innovative work has led to the development of a new peptide antibiotic that holds promise for improving animal health, particularly in poultry.

Latest Patents

Papiska holds a patent for A54145, which details a novel antibiotic and the process for its production. The patent describes individual components of the antibiotic, including A, A.sub.1, B, B.sub.1, C, D, E, and F, along with their pharmaceutically acceptable salts. These components are recognized as effective antibacterial agents that also enhance growth performance in animals. The patent further includes biologically pure cultures of the A54145-producing Streptomyces fradiae cultures NRRL 18158, NRRL 18159, and NRRL 18160, along with methods for producing antibiotic A54145 using these cultures.

Career Highlights

Papiska has made significant strides in his career, working with Eli Lilly and Company, a leading pharmaceutical firm. His work has not only contributed to the advancement of antibiotic research but has also had a positive impact on animal health and agricultural practices.

Collaborations

Throughout his career, Papiska has collaborated with esteemed colleagues, including LaVerne D. Boeck and David S. Fukuda. These collaborations have fostered a productive environment for innovation and research in the field of antibiotics.

Conclusion

Harold R. Papiska's contributions to antibiotic development exemplify the importance of innovation in healthcare. His work continues to influence the industry and improve animal health outcomes.